| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/30/2005 | WO2005058338A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | WO2005058314A2 Methods for reducing the effects of stress on skin condition |
| 06/30/2005 | WO2005034917A3 Hydrophobic silica-based water powder |
| 06/30/2005 | WO2004078213A9 Composition for target substance introduction and method of target substance introduction |
| 06/30/2005 | WO2004058178A3 Uses of mammalian cytokine; related reagents |
| 06/30/2005 | WO2004055009A8 Novel compounds having selective inhibiting efect at gsk3 |
| 06/30/2005 | WO2004055006A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | WO2004055005A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | US20050143578 Compounds and methods |
| 06/30/2005 | US20050143466 drug delivery to infiltrate into spaces in skin; exposing skin to light energy to cause photosensitizing agent to become photodynamically activated; sebaceous gland disorder, sebum secretion, skin disorders |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143401 Anticancer agents; (4-(3-Fluorobenzyloxy)-3-chlorophenyl)-(6-(2-((2-methanesulphonyl-ethylamino)ethyl)-thiazol-4-yl)-quinazolin-4-yl)-amine |
| 06/30/2005 | US20050143393 Bactericides; infection therapy; topical administering |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143385 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/30/2005 | US20050143346 Blocks the phosphorylation of ceramide and sphingosine, thereby maintaining high concentration of ceramide and sphingosine; has inhibitory activity of sphingosine kinase |
| 06/30/2005 | US20050143345 Cosmetic scar management composition |
| 06/30/2005 | US20050143324 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye |
| 06/30/2005 | US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein) |
| 06/30/2005 | US20050143283 with a chelating agent; improves the solution stability; lyophilized; antithrombotic agent |
| 06/30/2005 | US20050142659 Purified populations of stem cells |
| 06/30/2005 | US20050142636 Culturing yeast transformed with albumin-encoding nucleotide sequence in a fermentation medium; gene expression, separation, conditioning, adding sodium octanoate; cationic exchange chromatography, elution, ultrafiltration, sterilization, diafiltration, filling vessel |
| 06/30/2005 | US20050142546 Assays for identifying modulators of rhomboid polypeptides |
| 06/30/2005 | US20050142208 Pharmceutical composition for treatment of wounds conntaining blood plasma or serum |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050142138 Endothelial cell expression patterns |
| 06/30/2005 | US20050142110 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 06/30/2005 | US20050142092 Cosmetic or dermopharmaceutical compositions which are used to reduce bags and circles under the eyes |
| 06/30/2005 | US20050142088 Hair growth stimulants, percutaneous preparations and method of stimulating hair growth |
| 06/30/2005 | US20050142081 Cosmetic or dermatological composition comprising an association between a compound of the N-acylaminoamide family and at least on matrix metalloproteinase inhibitor |
| 06/30/2005 | US20050142078 Method of stimulation of melanin production and induction of skin tanning |
| 06/30/2005 | DE10357452A1 Kosmetische Zubereitungen mit einem Gehalt an Licochalcon A oder einem Extrakt aus Radix Glycyrrhizae inflatae, enthaltend Licochalcon A, und organischen Verdicker Cosmetic preparations containing licochalcone A or an extract from Radix Glycyrrhizae inflatae containing licochalcone A, and organic thickeners |
| 06/30/2005 | CA2580663A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | CA2549878A1 Glycosylation-deficient hepatocyte growth factor |
| 06/30/2005 | CA2549509A1 Composition for improving skin, hair and coat health containing flavanones |
| 06/30/2005 | CA2545760A1 Use of ondansetron for the treatment of inflammation, and pharmaceutical compositions thereof |
| 06/29/2005 | EP1548121A1 Novel physiologically active substances |
| 06/29/2005 | EP1548032A1 Kdr peptides and vaccines comprising the same |
| 06/29/2005 | EP1548015A1 Novel crystals |
| 06/29/2005 | EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same |
| 06/29/2005 | EP1548003A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 06/29/2005 | EP1547616A1 Preventive and/or therapeutic drugs for itch |
| 06/29/2005 | EP1547606A1 Method of preparing platelet rich plasma |
| 06/29/2005 | EP1547602A1 External preparation for inhibiting keloid formation |
| 06/29/2005 | EP1547594A1 Preventive or remedy for bedsore |
| 06/29/2005 | EP1547590A1 Melanin extinguisher |
| 06/29/2005 | EP1547578A2 Use of a steroidal or non-steroidal EcR receptor ligand in a cosmetic or dermatological composition for maintaining the skin homeostasis |
| 06/29/2005 | EP1547577A1 Antiaging composition |
| 06/29/2005 | EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 06/29/2005 | EP1546152A1 Epothilone derivatives |
| 06/29/2005 | EP1546130A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 06/29/2005 | EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 06/29/2005 | EP1546084A1 2,4-dihydroxybenzoic acid derivatives |
| 06/29/2005 | EP1545619A2 Solution for ungual application |
| 06/29/2005 | EP1545591A2 Therapeutic use for lp229, in particular for wound healing |
| 06/29/2005 | EP1545572A2 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 06/29/2005 | EP1545565A1 Methods and compositions for tissue regeneration |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP1545516A2 Topical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 06/29/2005 | EP1545429A2 Methods and compositions for treatment of dermal conditions |
| 06/29/2005 | EP1408943B1 Pharmaceutical formulation containing an ltb4 antagonist and a wetting agent |
| 06/29/2005 | EP1286679B8 Skin treatment preparation |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP1172115B1 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
| 06/29/2005 | CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof |
| 06/29/2005 | CN1633444A 6-11 bicyclic ketolide derivatives |
| 06/29/2005 | CN1633437A Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 06/29/2005 | CN1633436A Pyrrolopyrimidine derivatives |
| 06/29/2005 | CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 06/29/2005 | CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1633292A Cotherapy with an oxazolidinone and a vitamin B |
| 06/29/2005 | CN1633287A Biphenil derivatives and their use as antiandrogenic agents |
| 06/29/2005 | CN1633286A Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 06/29/2005 | CN1633285A 组合物 The composition |
| 06/29/2005 | CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/29/2005 | CN1633280A Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
| 06/29/2005 | CN1633243A Pet food composition for skin photoprotection |
| 06/29/2005 | CN1631895A Preparation method of amygdalin and its application in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 06/29/2005 | CN1631421A Medicine for treating teen-ager's leukotrichia |
| 06/29/2005 | CN1631416A Medicine for treating broken tendon and trauma and preparing process thereof |
| 06/29/2005 | CN1631410A Medicinal ointment for treating onychomycosis, flat wart and cindyloma acuminatum |
| 06/29/2005 | CN1631402A Externally applied medicinal formulation for regenerating hair |
| 06/29/2005 | CN1631400A Beautifying powder |
| 06/29/2005 | CN1631385A Ointment for treating burn and scald and its preparing process |
| 06/29/2005 | CN1631381A Chinese traditional medicine for treating skin diseases |
| 06/29/2005 | CN1631369A Cream for treating skin disease |
| 06/29/2005 | CN1208336C Tert-butyl-(7-methyl-imidazo [1, 2-a] pyridine-3-yl)-amine derivatives |
| 06/29/2005 | CN1208322C Dihydroindole and tetrahydroquinoline derivatives |
| 06/29/2005 | CN1208079C Medicine for treating burn scald and frostbite |